Double-blind, placebo-controlled trial of methylphenidate in older, depressed, medically ill patients
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The authors examined the efficacy of methylphenidate in the treatment of depression in a group of older, medically ill patients. METHOD: Sixteen patients underwent an 8-day double-blind, randomized, placebo-controlled crossover trial; 13 completed the trial. RESULTS: Statistically and clinically significant treatment responses were found. CONCLUSIONS: These results support the use of methylphenidate in older, medically ill patients in whom rapid resolution of depressive symptoms is crucial.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A controlled trial of methyl phenidate (ritalin) in the treatment of depressive states
Robin, A. A., & Wiseberg, S. (1958) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.21.1.55 · Cited by 30
Cited by
Greenhill, L. L., Pliszka, S., & Dulcan, M. K. (2002) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200202001-00003 · Cited by 927
Are Mood Disorders and Obesity Related? A Review for the Mental Health Professional
McElroy, S. L., Kotwal, R., Malhotra, S., Nelson, E. B., Keck, P. E., & Nemeroff, C. B. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0507 · Cited by 652
Methylphenidate: Its Pharmacology and Uses
CHALLMAN, T. D., & LIPSKY, J. J. (2000) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(11)64618-1 · Cited by 553
Sheridan, P. L., & Hausdorff, J. M. (2007) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000105126 · Cited by 339
Gender differences in depression and response to psychotropic medication
Gorman, J. M. (2006) · Gender Medicine · doi:10.1016/s1550-8579(06)80199-3 · Cited by 195
Assessment and treatment of depression in the cancer patient
Newport, D. J., & Nemeroff, C. B. (1998) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(98)00011-7 · Cited by 167
Kok, R. M., Nolen, W. A., & Heeren, T. J. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.02.036 · Cited by 167
Psychostimulants for depression
Candy, B., Jones, L., Williams, R., Tookman, A., & King, M. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006722.pub2 · Cited by 156
The pharmacological management of depression
Kupfer, D. J. (2005) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2005.7.3/dkupfer · Cited by 69
“Therapeutic interest in psychostimulants has led to studies suggesting that methylphenidate is generally well tolerated and modestly efficacious for medically burdened depressed elders, but should only be used in the short term.(30) It is also appropriate to comment on the current status of herbal remedies for depress…”
BackgroundIglewicz, A., Morrison, K., Nelesen, R. A., Zhan, T., Iglewicz, B., Fairman, N., Hirst, J. M., & Irwin, S. A. (2015) · Psychosomatics · doi:10.1016/j.psym.2014.05.005 · Cited by 60
Depression Associated with Medical Illness: Treatment Considerations
Fava, G. A., & Sonino, N. (1996) · CNS Drugs · doi:10.2165/00023210-199605030-00004 · Cited by 53
Ng, C. G., Boks, M. P. M., Roes, K. C. B., Zainal, N. Z., Sulaiman, A. H., Tan, S. B., & de Wit, N. J. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.01.016 · Cited by 52
“…randomized controlled studies and case studies also reported a positive effect of the use of methylphenidate in terminally ill elderly without cancer with refractory depression (Wallace et al., 1995; Bader et al., 1998; Homsi et al., 2001; Lavretsky et al., 2006; Buhagiar and Cassar, 2007).”
BackgroundInfluentialAssessment of stimulant use and cardiovascular event risks among older adults
Tadrous, M., Shakeri, A., Chu, C., Watt, J., Mamdani, M. M., Juurlink, D. N., & Gomes, T. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.30795 · Cited by 49
Use of adjunctive stimulants in adult bipolar depression
Dell'Osso, B., & Ketter, T. A. (2013) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712000326 · Cited by 31
“Furthermore, stimulants in general and methylphenidate, in particular, have been used in geriatric depression (Katon & Raskind, 1980 ; Wallace et al. 1995), post-stroke depression (Lazarus et al.”
BackgroundConzelmann, A., Woidich, E., Mucha, R. F., Weyers, P., Jacob, C. P., Lesch, K.-P., & Pauli, P. (2011) · Brain Research · doi:10.1016/j.brainres.2010.12.085 · Cited by 27
Metadata
- Venue
- American Journal of Psychiatry
- Published
- 1995-06-01
- Volume
- 152
- Issue
- 6
- Pages
- 929-931
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W21051842
- Cited by
- 115
- References
- 1
- FWCI
- 4.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.